Medical

Aspirin use reduces the risk of death from COVID-19

Aspirin COVID-19

In a recent study, hospitalized Covid-19 patients who took daily aspirin had lower risk of ICU admission, ventilation, and dying from SARS-CoV-2 virus.

COVID-19 patients who were taking a daily low-dose aspirin to protect against cardiovascular disease had a significantly reduced risk of complications and death compared to those who were not taking aspirin, according to a new study led by researchers at the University of Maryland School of Medicine (UMSOM).

Read more: More evidence that lack of Vitamin D is linked to COVID-19 severity

Covid-19 patients, under treatment at the American University of Maryland school of medicine, were analyzed. Out of the total corona patients, 412 were taking aspirin on daily basis. It was concluded that the patients who were using aspirin to protect against heart disease had a reduction in danger of death to the extent of 74%. The risk of death was reduced to the extent of 43% in shifting to ICU and the extent of 44% for shifting to a ventilator.

The researchers claimed that aspirin is a cheap medicine that can be highly useful for Covid-19 patients. Although aspirin is useful medicine yet it is highly advisable to use it after the consultation with the doctor as it has some side effects as well.

Use of this medicine must be stopped if the patient feels strange sounds in the ears, confusion, hallucinations, rapid breathing, seizure, severe nausea, vomiting or stomach pain, bloody or tarry stools, coughing up blood or vomit that looks like coffee grounds, fever lasting longer than 3 days, swelling or pain lasting longer than 10 days.

The medicine must not be used in a larger or smaller amount or longer than the recommendation of the doctor. In Pakistan, the cases of Corona are increasing again. It is required that the people of the country may be made aware of the outcome of this research through paper, electronic and social media.

Image source
To Top